DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

Not yet recruiting

Conditions: Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage I
Breast Cancer Stage III
Breast Carcinoma

First Posted Date: 2025-04-13

Last Posted Date: 2025-04-17

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 240

Registration Number: NCT06926530

Locations: 🇺🇸
Cleveland Clinic Florida, Weston, Florida, United States
🇺🇸
Cleveland Clinic Main Campus, Cleveland, Ohio, United States

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Phase 2

Not yet recruiting

Conditions: aGVHD
Acute Myelogenous Leukemia
Acute Lymphocytic Leukemia
Myelodysplastic Syndromes

Interventions: Biological: Haplo-Identical / Cord Blood Transplant

First Posted Date: 2025-04-01

Last Posted Date: 2025-05-07

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 36

Registration Number: NCT06904482

Locations: 🇺🇸
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio, United States

Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia

Recruiting

Conditions: Thrombocytopenia

First Posted Date: 2025-02-13

Last Posted Date: 2025-02-13

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06824727

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, United States

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

Not Applicable

Not yet recruiting

Conditions: Depression
Cancer
Stage III Breast Cancer
Stage II Breast Cancer
Stage I Breast Cancer
Stage III Prostate Cancer
Stage II Prostate Cancer
Stage I Prostate Cancer
Stage III Colorectal Cancer
Stage II Colorectal Cancer

First Posted Date: 2025-02-06

Last Posted Date: 2025-04-16

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 76

Registration Number: NCT06811454

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio, United States

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Phase 2

Not yet recruiting

Conditions: Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer

Interventions: Drug: Cabazitaxel and carboplatin
Drug: Lu-PSMA-617

First Posted Date: 2024-12-17

Last Posted Date: 2025-04-24

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 44

Registration Number: NCT06738303

Locations: 🇺🇸
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

Not Applicable

Recruiting

Conditions: Barrett Esophagus
Gastroesophageal Reflux
Esophageal Adenocarcinoma

First Posted Date: 2024-11-13

Last Posted Date: 2025-03-14

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 800

Registration Number: NCT06687603

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

and more 2 locations

ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy

Not Applicable

Not yet recruiting

Conditions: Febrile Neutropenia

First Posted Date: 2024-10-24

Last Posted Date: 2024-12-18

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT06657183

Locations: 🇺🇸
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio, United States

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

Recruiting

Conditions: Graft Vs Host Disease
Vulvovaginal Signs and Symptoms

First Posted Date: 2024-10-18

Last Posted Date: 2025-03-13

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06649201

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

Phase 2

Not yet recruiting

Conditions: Oral Squamous Cell Carcinoma
Oral Cancer
Head and Neck Cancer
Head and Neck Carcinoma

Interventions: Drug: Metronidazole
Other: Chlorhexidine

First Posted Date: 2024-10-04

Last Posted Date: 2025-03-11

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 30

Registration Number: NCT06627270

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio, United States

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Phase 1

Not yet recruiting

Conditions: Hepato Cellular Carcinoma (HCC)

Interventions: Drug: BC3402
Drug: Durvalumab
Drug: Tremelimumab

First Posted Date: 2024-09-23

Last Posted Date: 2025-01-06

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 43

Registration Number: NCT06608940

Locations: 🇺🇸
Case Comprehensive Cancer Center Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy